Sequential vidarabine infusion in the treatment of polyoma virus-associated acute haemorrhagic cystitis late after allogeneic bone marrow transplantation

Bone Marrow Transplant. 2000 Feb;25(3):319-20. doi: 10.1038/sj.bmt.1702129.

Abstract

Late onset haemorrhagic cystitis (HC) occurs in 20-30% of allogeneic bone marrow transplant patients. Human polyomavirus BK (BKV) (or less frequently adenovirus) may be involved in the pathogenesis of viral HC and can represent a serious post-transplant complication. Diagnosis and treatment of viral HC can be difficult and has an uncertain outcome. We report the efficacy of sequential vidarabine in the treatment of a patient with severe BKV-associated HC, despite the delay in implementing therapy. Bone Marrow Transplantation (2000) 25, 319-320.

Publication types

  • Case Reports

MeSH terms

  • Acute Disease
  • Antibiotic Prophylaxis
  • Bone Marrow Transplantation / adverse effects*
  • Cystitis / drug therapy*
  • Cystitis / etiology
  • Cystitis / virology*
  • Diarrhea
  • Fatal Outcome
  • Hematuria / drug therapy
  • Hematuria / etiology
  • Hematuria / virology
  • Hemorrhage / drug therapy
  • Hemorrhage / etiology
  • Hemorrhage / virology
  • Humans
  • Leukemia, Myeloid / therapy
  • Male
  • Middle Aged
  • Polyomavirus Infections*
  • Polyomavirus*
  • Time Factors
  • Transplantation, Homologous / adverse effects
  • Tumor Virus Infections*
  • Vidarabine / administration & dosage*

Substances

  • Vidarabine